B. Schechter et al., Organ selective delivery using a tissue-directed sreptavidin-biotin system: Targeting 5-fluorouridine via TNP-streptavidin, J DRUG TAR, 6(5), 1999, pp. 337-348
Trinitrophenyl (TNP) modification of streptavidin (St) resulted in high and
prolonged accumulation in mouse liver following intravenous administration
of radioiodinated TNP streptavidin (TNP-St). Uptake, which is correlated w
ith increased TNP substitution, was first observed at 2-3 h: increased to 4
0-50% of injected dose/gram tissue (%/g) at 24 h and slowly declined later
on. A low degree of accumulation (10 %/g) was observed in the spleen. TNP s
ubstitution of other proteins such as bovine serum albumin (BSA) or ovalbum
in (Ova) led to a transient short-term liver uptake. The enzyme-resistance
property of streptavidin and its biotin binding sites render TNP-modified s
treptavidin a potential targeting vehicle to the liver. 5-Fluorouridine (FU
R) was attached to high molecular weight carrier carboxymethyldextran (CMde
x, derived from 40 kDa dextran) and the dextran-FUR conjugate was charged w
ith 2-4 biotinyl groups (in the form of biotinyldiaminopropionyl-tyrosine,
BDT) for complexing to TNP-St. Biodistribution monitoring of the BDT-CMdex-
FUR ligand, radio labeled at the tyrosyl residue of BDT and targeted via no
n-radiolabeled TNP-St, showed that ligand accumulation in the liver was sim
ilar to TNP-St itself. Liver targeting of FUR was demonstrated by trace-lab
eling FUR with its structural analog 5,6-[H-3] uridine prior to conjugation
to dextran hydrazide. Specific liver accumulation of [H-3] radioactivity o
ccurred following administration of the conjugate only when complexed to TN
P-St. Hepatic levels of [H-3] radioactivity were in the range of 25%/g or 3
5% per whole liver during a period of at least 8 h, as compared to the rapi
d elimination of free FUR+[H-3]uridine (4%/g at 20 min). [H-3]-drug radioac
tivity disappeared at a faster rate as compared to (125)-I-dextran radioact
ivity, suggesting that metabolic processes required to generate the 5,6[H-3
]uracil-containing active metabolites took place.